LY3549492

LY3549492 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for LY3549492, covering 2024-05-30 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3549492 in Japanese Participants With Type 2 Diabetes Mellitus (T2D) and Healthy Japanese Participants [Phase 1]

See pricing